The mechanism of hallucinations caused by lysergic acid diethylamide
DOI:
https://doi.org/10.61173/djr26b21Keywords:
LSD, hallucination, hallucinogens, 5-HT receptorsAbstract
Lysergic acid diethylamide (LSD) is a semi-synthetic hallucinogen that induces intense hallucinogenic effects. There are various ways that hallucinations can occur, but classic psychedelics like LSD differ significantly in their effects from those caused by other means. The primary focus of current research is on activating 5-HT2A receptors within the serotonin system, which is essential for causing hallucinations and related behavioral responses in humans. In addition, through functional magnetic resonance imaging (fMRI), people can clearly observe the changes in cerebral blood flow influenced by LSD. This research presents the mechanism behind LSD’s hallucinatory effects from perspectives such as molecular biology and neuroanatomy spanning nearly half a century. As the understanding of its mechanism deepens, it can link the hallucinations caused by LSD to perceptual disorders and other diseases in humans, thus identifying more treatment methods. The analysis of the hallucination mechanism can also be beneficial for developing new treatment methods and understanding the specific physiological changes caused by drugs in hallucinations.
References
[1] Halberstadt A L. Recent advances in the neuropsy chopharmacology of serotonergic hallucinogens. Behavioural brain research, 2015, 277: 99-120.
[2] De Gregorio D, Enns J P, Nuñez N A, et al. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders. Progress in brain research, 2018, 242: 69-96.
[3] O’Brien J, Taylor J P, Ballard C, et al. Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. Journal of Neurology, Neurosurgery & Psychiatry, 2020, 91(5): 512-519.
[4] Sun Yi, Su Ruibin Research progress on the pharmacological effects and mechanisms of hallucinogens. Chinese Journal of Pharmacology and Toxicology, 2021, 35 (4): 241-250
[5] Jing Xin. Pharmacological effects and abuse of hallucinogens. Chinese Journal of Drug Dependence, 1989, 4: 20-24
[6] Pehek EA, McFarlane HG, Maguschak K, ezt al. M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res, 2001, 888(1):51-59.
[7] Carhart-Harris R L, Muthukumaraswamy S, Roseman L, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences, 2016, 113(17): 4853-4858.
[8] Preller K H, Burt J B, Ji J L, et al. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. Elife, 2018, 7: e35082.
[9] Mastinu A, Anyanwu M, Carone M, et al. The bright side of psychedelics: latest advances and challenges in neuropharmacology. International Journal of Molecular Sciences, 2023, 24(2): 1329.
[10] Passie T, Halpern J H, Stichtenoth D O, et al. The pharmacology of lysergic acid diethylamide: a review. CNS neuroscience & therapeutics, 2008, 14(4): 295-314.
[11] López-Giménez J F, González-Maeso J. Hallucinogens and serotonin 5-HT 2A receptor-mediated signaling pathways. Behavioral neurobiology of psychedelic drugs, 2018: 45-73.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
